Gemtaz Infusmart 1.6g Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Gemcitabine (1600mg)
Overview Gemtaz Infusmart 1.6g Injection
Infusmart Gemtaz 1.6g Injection treats various cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can lower blood cell counts, increasing infection risk. Regular blood tests monitoring blood cell levels, heart, liver function, and uric acid are essential. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent infection treatments, before commencing therapy. Drug interactions are possible; disclose all medications to your physician. This injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Primary Ingredients of Gemtaz Infusmart 1.6g Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Gemtaz Infusmart 1.6g Injection
Lung cancer (non-small cell), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Gemtaz Infusmart 1.6g Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Gemtaz Infusmart 1.6g Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemtaz Infusmart 1.6g Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gemtaz Infusmart 1.6g Injection works:
Gemtaz Infusmart 1.6g Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential cellular components. This action inhibits further tumor growth and expansion.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemtaz Infusmart 1.6g Injection and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gemtaz Infusmart 1.6g Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
The administration of Gemtaz Infusmart 1.6g Injection is contraindicated during lactation due to potential infant toxicity.
DrivingUNSAFE
Administering Gemtaz Infusmart 1.6g Injection might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemtaz Infusmart 1.6g Injection's use in individuals with renal impairment. Physician consultation is necessary. Pre-treatment and post-treatment kidney function assessments are recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gemtaz Infusmart 1.6g Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemtaz Infusmart 1.6g Injection :
NA
Facts to Know About Gemtaz Infusmart 1.6g Injection
| Label | Value |
|---|---|
| Chemical Type | Cytosine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic Inhibitors |
3,018 People bought this recently